Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for L-Theanine.
L-Theanine is a non-proteinogenic amino acid that modulates alpha-wave brain activity and antagonizes glutamate receptors to facilitate anxiolysis and cognitive focus without inducing somnolence.
439378
174.20 g/mol
-3.6
(2S)-2-amino-5-(ethylamino)-5-oxopentanoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for L-Theanine across standard consumer modalities.
The material is generally stable but requires low-moisture excipients to prevent clumping due to its slight hygroscopicity in high-humidity environments.
L-Theanine's umami flavor profile can interfere with fruit-based acidulants, requiring specific flavor masking to prevent a savory aftertaste in the pectin matrix.
The standard therapeutic dose of 100-200mg exceeds the typical 20-50mg payload capacity of standard thin-film polymers, necessitating specialized high-loading film technology.
Ready to launch a product featuring L-Theanine? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your L-Theanine extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your L-Theanine payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation